Cannabis-Induced Extrapyramidalism in a Patient on Neuroleptic Treatment
Authors:
- Carlos Rejón AltableCACarlos Rejón Altable
- Amanda Rodríguez UrrutiaAUAmanda Rodríguez Urrutia
- Ma. Isabel Carrión MartínezMMMa. Isabel Carrión Martínez
- 1 February 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 25 (1) , 91-92
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Causal association between cannabis and psychosis: examination of the evidenceThe British Journal of Psychiatry, 2004
- Delta 9-Tetrahydrocannabinol (THC) is Effective in the Treatment of Tics in Tourette SyndromeThe Journal of Clinical Psychiatry, 2003
- Randomised, double‐blind, placebo‐controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystoniaMovement Disorders, 2002
- Comorbid non-alcohol substance misuse among people with schizophreniaThe British Journal of Psychiatry, 2001
- Cannabis Use and Psychosis: A Review of Clinical and Epidemiological EvidenceAustralian & New Zealand Journal of Psychiatry, 2000
- Tricyclic antidepressant-induced extrapyramidal side effects.European Neuropsychopharmacology, 1997
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- Parkinsonism induced by high doses of diazepamBiological Psychiatry, 1985